vs

Side-by-side financial comparison of COMPUGEN LTD (CGEN) and Where Food Comes From, Inc. (WFCF). Click either name above to swap in a different company.

Where Food Comes From, Inc. is the larger business by last-quarter revenue ($6.0M vs $3.5M, roughly 1.7× COMPUGEN LTD). Where Food Comes From, Inc. runs the higher net margin — -3.4% vs -410.1%, a 406.8% gap on every dollar of revenue. On growth, Where Food Comes From, Inc. posted the faster year-over-year revenue change (-9.3% vs -61.8%). Where Food Comes From, Inc. produced more free cash flow last quarter ($-741.0K vs $-18.8M).

Compugen Ltd. is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Compugen was established as computational drug discovery service provider in 1993. Compugen originally acted as service provider for pharma companies, supplying its software and computational services to predict different types of biological phenomena. It had arrangements with big compan...

Where Food Comes From, Inc. is a leading provider of food traceability, verification, and certification solutions for the agricultural and food production industries. Its services support producers, processors, and retailers across North America to validate food origin, sustainability practices, animal welfare standards, and product authenticity for end consumers.

CGEN vs WFCF — Head-to-Head

Bigger by revenue
WFCF
WFCF
1.7× larger
WFCF
$6.0M
$3.5M
CGEN
Growing faster (revenue YoY)
WFCF
WFCF
+52.5% gap
WFCF
-9.3%
-61.8%
CGEN
Higher net margin
WFCF
WFCF
406.8% more per $
WFCF
-3.4%
-410.1%
CGEN
More free cash flow
WFCF
WFCF
$18.1M more FCF
WFCF
$-741.0K
$-18.8M
CGEN

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
CGEN
CGEN
WFCF
WFCF
Revenue
$3.5M
$6.0M
Net Profit
$-14.5M
$-203.0K
Gross Margin
35.9%
Operating Margin
-475.1%
-1.0%
Net Margin
-410.1%
-3.4%
Revenue YoY
-61.8%
-9.3%
Net Profit YoY
-54.7%
-121.1%
EPS (diluted)
$-0.16
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CGEN
CGEN
WFCF
WFCF
Q4 25
$6.0M
Q3 25
$7.0M
Q2 25
$3.5M
$6.6M
Q1 25
$5.3M
Q4 24
$6.7M
Q3 24
$7.1M
Q2 24
$9.3M
$6.4M
Q1 24
$2.6M
$5.6M
Net Profit
CGEN
CGEN
WFCF
WFCF
Q4 25
$-203.0K
Q3 25
$1.1M
Q2 25
$-14.5M
$562.0K
Q1 25
$31.0K
Q4 24
$961.0K
Q3 24
$492.0K
Q2 24
$-9.4M
$489.0K
Q1 24
$7.3M
$178.0K
Gross Margin
CGEN
CGEN
WFCF
WFCF
Q4 25
35.9%
Q3 25
38.3%
Q2 25
37.5%
Q1 25
41.6%
Q4 24
42.0%
Q3 24
39.0%
Q2 24
60.5%
41.6%
Q1 24
17.9%
41.7%
Operating Margin
CGEN
CGEN
WFCF
WFCF
Q4 25
-1.0%
Q3 25
8.2%
Q2 25
-475.1%
8.4%
Q1 25
2.7%
Q4 24
11.3%
Q3 24
8.6%
Q2 24
-128.5%
9.1%
Q1 24
4.7%
Net Margin
CGEN
CGEN
WFCF
WFCF
Q4 25
-3.4%
Q3 25
16.3%
Q2 25
-410.1%
8.6%
Q1 25
0.6%
Q4 24
14.4%
Q3 24
6.9%
Q2 24
-101.4%
7.6%
Q1 24
284.0%
3.2%
EPS (diluted)
CGEN
CGEN
WFCF
WFCF
Q4 25
$-0.04
Q3 25
$0.22
Q2 25
$-0.16
$0.11
Q1 25
$0.01
Q4 24
$0.19
Q3 24
$0.09
Q2 24
$-0.10
$0.09
Q1 24
$89505618.00
$0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CGEN
CGEN
WFCF
WFCF
Cash + ST InvestmentsLiquidity on hand
$35.3M
$3.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$50.3M
$9.3M
Total Assets
$106.5M
$12.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CGEN
CGEN
WFCF
WFCF
Q4 25
$3.2M
Q3 25
$4.8M
Q2 25
$35.3M
$3.2M
Q1 25
$2.2M
Q4 24
$2.0M
Q3 24
$2.8M
Q2 24
$44.6M
$2.6M
Q1 24
$39.3M
$1.9M
Stockholders' Equity
CGEN
CGEN
WFCF
WFCF
Q4 25
$9.3M
Q3 25
$10.3M
Q2 25
$50.3M
$10.0M
Q1 25
$9.6M
Q4 24
$9.9M
Q3 24
$9.5M
Q2 24
$58.3M
$9.7M
Q1 24
$65.6M
$9.6M
Total Assets
CGEN
CGEN
WFCF
WFCF
Q4 25
$12.9M
Q3 25
$16.9M
Q2 25
$106.5M
$16.6M
Q1 25
$15.2M
Q4 24
$15.3M
Q3 24
$16.9M
Q2 24
$110.2M
$16.8M
Q1 24
$121.3M
$15.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CGEN
CGEN
WFCF
WFCF
Operating Cash FlowLast quarter
$-18.6M
$-707.0K
Free Cash FlowOCF − Capex
$-18.8M
$-741.0K
FCF MarginFCF / Revenue
-530.8%
-12.3%
Capex IntensityCapex / Revenue
6.5%
0.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CGEN
CGEN
WFCF
WFCF
Q4 25
$-707.0K
Q3 25
$501.0K
Q2 25
$-18.6M
$1.2M
Q1 25
$632.0K
Q4 24
$-50.0K
Q3 24
$912.0K
Q2 24
$39.7M
$1.2M
Q1 24
$700.0K
Free Cash Flow
CGEN
CGEN
WFCF
WFCF
Q4 25
$-741.0K
Q3 25
$443.0K
Q2 25
$-18.8M
$1.1M
Q1 25
$603.0K
Q4 24
$-79.0K
Q3 24
$873.0K
Q2 24
$39.7M
$1.1M
Q1 24
$676.0K
FCF Margin
CGEN
CGEN
WFCF
WFCF
Q4 25
-12.3%
Q3 25
6.3%
Q2 25
-530.8%
17.5%
Q1 25
11.4%
Q4 24
-1.2%
Q3 24
12.3%
Q2 24
428.3%
17.2%
Q1 24
12.1%
Capex Intensity
CGEN
CGEN
WFCF
WFCF
Q4 25
0.6%
Q3 25
0.8%
Q2 25
6.5%
0.5%
Q1 25
0.5%
Q4 24
0.4%
Q3 24
0.5%
Q2 24
0.4%
1.0%
Q1 24
0.4%
Cash Conversion
CGEN
CGEN
WFCF
WFCF
Q4 25
Q3 25
0.44×
Q2 25
2.10×
Q1 25
20.39×
Q4 24
-0.05×
Q3 24
1.85×
Q2 24
2.39×
Q1 24
3.93×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CGEN
CGEN

Segment breakdown not available.

WFCF
WFCF

Verification And Certification Service Revenue$5.0M83%
Other$1.0M17%

Related Comparisons